The Cigna Group declares $1.56 quarterly dividend

scanx
Reviewed by
Ashish TScanX News Team
Key Highlights

The Cigna Group's Board declared a $1.56 per share cash dividend payable on September 23, 2026, to shareholders of record on September 8, 2026. The company operates globally through Cigna Healthcare and Evernorth Health Services.

powered bylight_fuzz_icon
46313513

*this image is generated using AI for illustrative purposes only.

The Cigna Group has declared a cash dividend of $1.56 per share on its common stock, providing income to shareholders as the company continues its operations in the global health services market. The Board of Directors approved the dividend on July 22, 2026, marking the latest distribution to investors holding the company's equity.

The payment is scheduled for September 23, 2026. To qualify for the dividend, investors must be recorded as shareholders of the company by the close of business on September 8, 2026. This record date determines the eligibility of shareholders to receive the upcoming payout.

Key Dividend Details

Detail Date/Amount
Dividend per share $1.56
Record date September 8, 2026
Payment date September 23, 2026

The Cigna Group operates as a global health company, offering products and services through Cigna Healthcare and Evernorth Health Services. The organization maintains sales capabilities in over 30 markets and jurisdictions, serving more than 180 million customer relationships worldwide.

How does this dividend declaration compare to previous payouts, and does it signal a shift in Cigna's capital allocation strategy?

What impact will this distribution have on Cigna's ability to fund future acquisitions or expansion in the global health services market?

How might the dividend yield influence investor sentiment amidst current volatility in the healthcare sector?

like19
dislike

Bernstein raises Cigna Group price target to $381

scanx
Reviewed by
Radhika SScanX News Team
Key Highlights

Bernstein analyst Lance Wilkes maintained an Outperform rating on Cigna Group and raised the price target to $381 from $371, signaling a positive outlook.

powered bylight_fuzz_icon
45149600

*this image is generated using AI for illustrative purposes only.

Bernstein analyst Lance Wilkes has maintained an Outperform rating on Cigna Group, raising the price target to $381 from $371. The revised target indicates an increased valuation outlook for the healthcare company's stock.

The rating affirmation and price target adjustment were detailed in a recent research note. Cigna Group trades on the NYSE under the ticker CI.

What specific factors drove Bernstein to raise Cigna's price target?

How might Cigna's recent performance influence its competitive position in the healthcare sector?

What are the potential risks that could prevent Cigna from reaching the new price target?

like18
dislike

More News on The Cigna Group